Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Purpose: to evaluate the safety and efficacy of phacoemulsification as a first line treatment of acute angle closure glaucoma (AACG) and to evaluate the preoperative and postoperative anterior chamber angle width using anterior segment OCT(AS-OCT). Sittings: Sohag University Hospital, Sohag city, Egypt. Design: Prospective comparative interventional case series study Methods: Patients presented with AACG. After control of high IOP, all participants were scheduled for phacoemulsification within a week after the attack. Preoperative and postoperative angle width was measured by AS-OCT to evaluate angle changes. Results: Fifty eyes with AACG were enrolled in the study. The mean preoperative IOP was 40.3±10.4 mmHg. This acute rise of IOP was dramatically lowered to 14.9±3.9 in the first week after phacoemulsification. Further reduction of IOP continued 4 weeks and 12 weeks postoperative with values of 12.4±3.5 and 11.44±3.31. The mean preoperative temporal angle width was 18.13±3.65. In the first postoperative week the temporal angle widened to 32.64±4.25. further widening of the temporal angle occurred 4 weeks and 12 weeks postoperative to 34.64±4.37 and 36.16±4.46 respectively. The mean preoperative nasal angle width was 17.80±3.45. In the first postoperative week the nasal angle widened to 32.74±4.22. further widening of the nasal angle occurred 4 weeks and 12 weeks postoperative to 34.50±4.48 and 36.18±4.47 respectively Conclusion: Early phacoemulsification is very effective in treatment of acute angle closure glaucoma cases immediately after medical control of high IOP and resolution of corneal oedema. This was proved by imaging and measuring the angle width using
Purpose: to evaluate the safety and efficacy of phacoemulsification as a first line treatment of acute angle closure glaucoma (AACG) and to evaluate the preoperative and postoperative anterior chamber angle width using anterior segment OCT(AS-OCT). Sittings: Sohag University Hospital, Sohag city, Egypt. Design: Prospective comparative interventional case series study Methods: Patients presented with AACG. After control of high IOP, all participants were scheduled for phacoemulsification within a week after the attack. Preoperative and postoperative angle width was measured by AS-OCT to evaluate angle changes. Results: Fifty eyes with AACG were enrolled in the study. The mean preoperative IOP was 40.3±10.4 mmHg. This acute rise of IOP was dramatically lowered to 14.9±3.9 in the first week after phacoemulsification. Further reduction of IOP continued 4 weeks and 12 weeks postoperative with values of 12.4±3.5 and 11.44±3.31. The mean preoperative temporal angle width was 18.13±3.65. In the first postoperative week the temporal angle widened to 32.64±4.25. further widening of the temporal angle occurred 4 weeks and 12 weeks postoperative to 34.64±4.37 and 36.16±4.46 respectively. The mean preoperative nasal angle width was 17.80±3.45. In the first postoperative week the nasal angle widened to 32.74±4.22. further widening of the nasal angle occurred 4 weeks and 12 weeks postoperative to 34.50±4.48 and 36.18±4.47 respectively Conclusion: Early phacoemulsification is very effective in treatment of acute angle closure glaucoma cases immediately after medical control of high IOP and resolution of corneal oedema. This was proved by imaging and measuring the angle width using
Purpose. To compare the effects of early phacoemulsification and intraocular lens implantation (phaco/IOL), delayed phaco/IOL after initial laser peripheral iridotomy (LPI), and conventional LPI alone in patients with acute primary angle-closure (PAC). Methods. Patients with acute PAC were included in the study, and those with secondary glaucoma, prior ocular trauma, or other ocular diseases and those who had undergone ocular surgeries previously were excluded. Patients were categorized into three groups: Group A, which underwent primary phaco/IOL after acute PAC; Group B, which underwent LPI initially after acute PAC, followed by phaco/IOL within 6 months; and Group C, which underwent LPI alone. The IOP control success at 12 months as well as changes in ocular characteristics and the number of antiglaucoma medications used after the treatment among the groups were evaluated. Results. Eighty-one eyes were included in the study: 24 eyes in Group A, 23 eyes in Group B, and 34 eyes in Group C. The linear mixed model analysis demonstrated considerable IOP control in Groups A and B. Visual acuity, anterior chamber depth (ACD), and angle width improved significantly in Groups A and B, but not in Group C. The number of antiglaucoma medications used was significantly higher in Group C than in Groups A and B. Conclusions. Patients who underwent phaco/IOL had better IOP control, improved vision, deeper ACD, and wider angle and required less antiglaucoma medications than those who underwent LPI alone. Performing phaco/IOL weeks to months after the initial LPI did not appear to adversely affect outcomes compared with those of early phaco/IOL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.